Modalis Therapeutics Corporation (TYO:4883)
90.00
+1.00 (1.12%)
Aug 19, 2025, 10:44 AM JST
Modalis Therapeutics Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Cash & Equivalents | 3,262 | 3,575 | 1,883 | 2,933 | 4,936 | 5,421 | Upgrade |
Cash & Short-Term Investments | 3,262 | 3,575 | 1,883 | 2,933 | 4,936 | 5,421 | Upgrade |
Cash Growth | 155.22% | 89.86% | -35.80% | -40.58% | -8.95% | 40.55% | Upgrade |
Receivables | 37.19 | - | - | - | - | - | Upgrade |
Inventory | - | - | 6 | 40 | - | - | Upgrade |
Other Current Assets | 50.1 | 42 | 67 | 88 | 131 | 27 | Upgrade |
Total Current Assets | 3,349 | 3,617 | 1,956 | 3,061 | 5,067 | 5,448 | Upgrade |
Property, Plant & Equipment | - | - | - | - | 223 | 49 | Upgrade |
Long-Term Investments | 67.36 | 74 | 69 | 68 | 73 | 10 | Upgrade |
Other Intangible Assets | - | - | - | - | 705 | 767 | Upgrade |
Other Long-Term Assets | 0 | - | - | - | 1 | 3 | Upgrade |
Total Assets | 3,416 | 3,691 | 2,025 | 3,129 | 6,069 | 6,277 | Upgrade |
Accounts Payable | 72.16 | 1 | - | - | 1 | - | Upgrade |
Accrued Expenses | 86.76 | 20 | 91 | 17 | 25 | 17 | Upgrade |
Current Income Taxes Payable | 11.15 | 95 | 105 | 123 | 126 | 39 | Upgrade |
Other Current Liabilities | 1.82 | 1 | 2 | 1 | 28 | 2 | Upgrade |
Total Current Liabilities | 171.89 | 117 | 198 | 141 | 180 | 58 | Upgrade |
Long-Term Debt | - | - | 412 | - | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | - | - | 5 | 11 | Upgrade |
Other Long-Term Liabilities | 56.93 | 28 | 36 | 49 | 335 | 1 | Upgrade |
Total Liabilities | 228.82 | 145 | 646 | 190 | 520 | 70 | Upgrade |
Common Stock | 1,372 | 1,758 | 1,217 | 2,094 | 2,744 | 2,707 | Upgrade |
Additional Paid-In Capital | 2,694 | 3,080 | 2,539 | 3,416 | 4,066 | 4,029 | Upgrade |
Retained Earnings | -904.99 | -1,325 | -2,410 | -2,605 | -1,266 | -527 | Upgrade |
Comprehensive Income & Other | 26.45 | 33 | 33 | 34 | 5 | -2 | Upgrade |
Shareholders' Equity | 3,188 | 3,546 | 1,379 | 2,939 | 5,549 | 6,207 | Upgrade |
Total Liabilities & Equity | 3,416 | 3,691 | 2,025 | 3,129 | 6,069 | 6,277 | Upgrade |
Total Debt | - | - | 412 | - | - | - | Upgrade |
Net Cash (Debt) | 3,262 | 3,575 | 1,471 | 2,933 | 4,936 | 5,421 | Upgrade |
Net Cash Growth | 192.26% | 143.03% | -49.85% | -40.58% | -8.95% | 40.55% | Upgrade |
Net Cash Per Share | 49.88 | 77.50 | 47.50 | 100.77 | 171.67 | 205.73 | Upgrade |
Filing Date Shares Outstanding | 76.93 | 73.55 | 33.81 | 30.09 | 29.04 | 28.56 | Upgrade |
Total Common Shares Outstanding | 76.93 | 69.4 | 33.36 | 29.36 | 28.97 | 28.52 | Upgrade |
Working Capital | 3,177 | 3,500 | 1,758 | 2,920 | 4,887 | 5,390 | Upgrade |
Book Value Per Share | 41.43 | 51.09 | 41.34 | 100.09 | 191.56 | 217.67 | Upgrade |
Tangible Book Value | 3,188 | 3,546 | 1,379 | 2,939 | 4,844 | 5,440 | Upgrade |
Tangible Book Value Per Share | 41.43 | 51.09 | 41.34 | 100.09 | 167.22 | 190.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.